These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 5212270)

  • 21. Which are the principal established or potential risks for donors undergoing cytapheresis procedures and how can they be prevented?
    Vox Sang; 1980 Sep; 39(3):169-79. PubMed ID: 7210606
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of plasmapheresis on immunoglobulin levels in blood donors].
    Yokoyama S; Matsuura N; Saji H; Hosoi T
    Rinsho Ketsueki; 1986 Jul; 27(7):1238-41. PubMed ID: 3784002
    [No Abstract]   [Full Text] [Related]  

  • 23. Training tank: a method for training technicians in ultrasound scanning.
    Holmes JH; Williams CL
    J Clin Ultrasound; 1973 Sep; 1(3):202-6. PubMed ID: 4203979
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative analysis of various plasmapheresis methods--modern procedures of mechanical plasma collection compared with each other and with manual bag centrifugation procedures].
    Neumeyer HF; Quentin SH; Wieding JU
    Beitr Infusionsther; 1993; 29():163-89. PubMed ID: 7690649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Practice Guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy.
    Anesthesiology; 1996 Mar; 84(3):732-47. PubMed ID: 8659805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transfusion requirements after bone marrow transplantation from HLA-identical siblings: effects of donor-recipient ABO incompatibility.
    Mehta J; Powles R; Singhal S; Horton C; Hamblin M; Zomas A; Saso R; Treleaven J
    Bone Marrow Transplant; 1996 Jul; 18(1):151-6. PubMed ID: 8832008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donor selection criteria to maximize double platelet products (DPP) by platelet apheresis.
    Wollersheim J; Dautzenberg M; van de Griendt A; Sybesma B
    Transfus Apher Sci; 2006 Apr; 34(2):179-86. PubMed ID: 16574489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Plasmapheresis under conditions of transfusion departments of the district type].
    Kulich V; Bufková D
    Cas Lek Cesk; 1969 Apr; 108(15):450-1. PubMed ID: 5779186
    [No Abstract]   [Full Text] [Related]  

  • 29. [Training of paramedical workers in the operation of medical equipment].
    Pakharin VI
    Med Sestra; 1982 May; 41(5):44-7. PubMed ID: 6211585
    [No Abstract]   [Full Text] [Related]  

  • 30. Additional standards for human blood and blood products; source plasma (human)--Food and Drug Administration. Final rule.
    Fed Regist; 1981 Nov; 46(226):57480-1. PubMed ID: 10253366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of granulocyte and platelet collection by semicontinuous plasmapheresis equipment (Hemonetics model 30) on blood donors: with special reference to the effects of high molecular hydroxyethyl starch].
    Shimoyama M; Minato K; Kitahara T
    Rinsho Ketsueki; 1981 Oct; 22(10):1661-6. PubMed ID: 6174751
    [No Abstract]   [Full Text] [Related]  

  • 32. Vincristine-laden platelet transfusion for patients with refractory thrombocytopenia.
    Ganti AK; Landmark JD; Kessinger A; Smith LM; Tarantolo SR
    In Vivo; 2006; 20(4):559-63. PubMed ID: 16900790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Quarantine and plasmapheresis].
    Ortiz Pareja M; Terol Fernández E; Hernández Lamas MC; Sánchez Gordo F
    Sangre (Barc); 1998 Jun; 43(3):261-2. PubMed ID: 9741240
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of long-term plasmapheresis on the donors blood picture].
    Smálik S; Beranová G; Filová J
    Bratisl Lek Listy; 1972 Nov; 58(5):545-57. PubMed ID: 4651574
    [No Abstract]   [Full Text] [Related]  

  • 35. Collection of source material from remunerated donors.
    Rodell MB
    Dev Biol Stand; 1993; 81():57-64. PubMed ID: 8174821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased ionized calcium during therapeutic plasma exchange pheresis and platelet pheresis.
    Morse EE; Hohnadel DC; Genco P; Katz AJ
    Johns Hopkins Med J; 1980 Jun; 146(6):260-3. PubMed ID: 7382251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maximum donation volumes per session in donor plasmapheresis.
    Karger R; Kretschmer V
    Vox Sang; 2006 Nov; 91(4):350; author reply 351-2. PubMed ID: 17105614
    [No Abstract]   [Full Text] [Related]  

  • 38. [The electrolyte content of donor blood in frequently repeated plasmapheresis].
    Gutnik RB; Zinevich AK
    Vrach Delo; 1968 Feb; 2():150-1. PubMed ID: 5669350
    [No Abstract]   [Full Text] [Related]  

  • 39. Morganella morganii causing fatal sepsis in a platelet recipient and also isolated from a donor's stool.
    Golubić-Cepulić B; Budimir A; Plecko V; Plenković F; Mrsić M; Sarlija D; Vuk T; Skrlin J; Kalenić S; Labar B
    Transfus Med; 2004 Jun; 14(3):237-40. PubMed ID: 15180816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New technologies for the inactivation of infectious pathogens in cellular blood components and the development of platelet substitutes.
    Corash L
    Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):549-63. PubMed ID: 11102276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.